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Abstract
Background: The anti-malarial chloroquine can modulate the outcome of infection during the
Plasmodium sporogonic development, interfering with Plasmodium gene expression and
subsequently, with transmission. The present study sets to identify Plasmodium genes that might be
regulated by chloroquine in the mosquito vector.
Methods: Differential display RT-PCR (DDRT-PCR) was used to identify genes expressed during
the sporogonic cycle that are regulated by exposure to chloroquine. Anopheles stephensi
mosquitoes were fed on Plasmodium yoelii nigeriensis-infected mice. Three days post-infection,
mosquitoes were fed a non-infectious blood meal from mice treated orally with 50 mg/kg
chloroquine. Two differentially expressed Plasmodium transcripts (Pyn_chl091 and Pyn_chl055)
were further characterized by DNA sequencing and real-time PCR analysis.
Results: Both transcripts were represented in Plasmodium EST databases, but displayed no
homology with any known genes. Pyn_chl091 was upregulated by day 18 post infection when the
mosquito had a second blood meal. However, when the effect of chloroquine on that transcript
was investigated during the erythrocytic cycle, no significant differences were observed. Although
slightly upregulated by chloroquine exposure the expression of Pyn_chl055 was more affected by
development, increasing towards the end of the sporogonic cycle. Transcript abundance of
Pyn_chl055 was reduced when erythrocytic stages were treated with chloroquine.
Conclusion: Chloroquine increased parasite load in mosquito salivary glands and interferes with
the expression of at least two Plasmodium genes. The transcripts identified contain putative signal
peptides and transmembrane domains suggesting that these proteins, due to their location, are
targets of chloroquine (not as an antimalarial) probably through cell trafficking and recycling.
Published: 2 July 2007
Malaria Journal 2007, 6:84 doi:10.1186/1475-2875-6-84
Received: 12 April 2007
Accepted: 2 July 2007
This article is available from: http://www.malariajournal.com/content/6/1/84
© 2007 Silveira et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 10
(page number not for citation purposes)
Malaria Journal 2007, 6:84 http://www.malariajournal.com/content/6/1/84Background
Malaria transmission starts when the anopheline mos-
quito takes an infected blood meal, initiating the sporo-
gonic cycle of the Plasmodium parasite. The full sporogonic
cycle varies in length, depending on species and tempera-
ture, and can take up to two weeks [1]. It is speculated that
since mosquitoes will have several blood meals during
their life span, components of this meal can interfere with
parasite development in the mosquito vector. In endemic
areas anti-malarial drugs, which are taken at regular basis
can end up in mosquito blood meals and, therefore, affect
parasite development [2].
The anti-malarial effect of chloroquine is observed on the
erythrocytic cycle of the parasite and has been associated
with haem detoxification. Although chloroquine is not
effective against the sporogonic cycle stages and although
the parasite environment during the sporogonic cycle is
not rich in haemoglobin, several reports have described
that this drug can modulate parasite development within
the mosquito. Early studies by Ramkaran and Peters [3]
associated chloroquine treatment with increased infectiv-
ity of drug-resistant parasites to the mosquito. Later, Hogh
et al. [2] reported that mosquitoes fed with Plasmodium
falciparum or Plasmodium berghei gametocytes in the pres-
ence of serum from chloroquine-treated human volun-
teers showed four to five fold increase in the mean oocyst
number and the same effect was also observed on Plasmo-
dium yoelii nigeriensis N67, which displayed enhanced
infectivity to mosquitoes when mice were treated with
chloroquine 12 hours prior feeding [4]. Higher parasite
loads were observed in salivary glands from mosquitoes
that had a second blood meal containing chloroquine
than those observed in non-chloroquine treated mosqui-
toes. This substantiates that chloroquine can modulate
Plasmodium mosquito infection, possibly acting on both
the parasite and the mosquito vector. Abrantes et al. [5]
demonstrated that chloroquine can modulate the mos-
quito immune response, probably contributing to the
infectivity differences observed. The present study shows
that chloroquine can interfere with parasite development
and can regulate the expression of parasite genes.
Methods
Experimental infections in mice
P. y. nigeriensis N67 were originally provided by Professor
D. Walliker (Edinburgh University). All infections were
performed in female BALB/C mice (four to six weeks old)
(Harlan Interfauna Ibérica SL, Barcelona, Spain). Parasit-
ized erythrocytes (PE) were derived from parasite donor
mice infected by intraperitoneal (i.p.) injection of cryop-
reserved stabilates. Mice were infected by i.p. injection of
1 × 106 P. y. nigeriensis PE/mouse. Daily individual parasi-
taemia were determined by counting the number of para-
sitized erythrocytes per 5,000 red blood cells on Giemsa-
stained tail-blood films. Exflagellation was investigated
before mosquito feeding.
Mosquito infections
Anopheles stephensi females (four to five days old) were
infected by feeding on P. y. nigeriensis-infected mice (with
patent exflagellation and 10–20% PE). Mosquitoes were
allowed feeding for one to two hours. Unfed mosquitoes
were discarded. Three days after infection, mosquitoes
were fed a second non-infective blood meal either on
BALB/c mice that were orally administrated 50 mg/Kg of
chloroquine 18 hours before the mosquito blood meal, or
on non-treated mice. Once again, mosquitoes were
allowed feeding for one to two hours and unfed mosqui-
toes were discarded. Mosquitoes were provided with 10%
glucose solution and 0.05% PABA, and were maintained
in experimental insectaries at 24 ± 0.5°C and 70 ± 5% rel-
ative humidity. The percentage of infected mosquitoes
and the number of oocyst per midgut were calculated by
optical microscopy observation of midguts at day 8 p.i
Isolation of total RNA and genomic DNA
Total RNA was isolated from mosquito midguts collected
at day 8 and 18 post infection (p.i.) and from mosquito
salivary glands at day 18 p.i. Tissues were kept on ice and
homogenized using a mortar and pastel. After grinding
TRIzol reagent (Invitrogen Corp., San Diego, Califomia)
was added and total RNA was purified as described by the
manufacturer. The integrity of RNA was confirmed by
electrophoresis on a denaturing formaldehyde/agarose
gel. Genomic DNA (gDNA) was isolated from blood stage
parasites (collected from infected mice to avoid mosquito
contamination) and from uninfected mosquitoes using
standard phenol/chloroform and precipitated with etha-
nol.
Differential mRNA display
RNA samples (1 μg total RNA) were treated with DNaseI
(Invitrogen) according to the manufacturer's protocol, in
order to eliminate possible DNA contamination. Comple-
mentary DNA was synthesized using a modification of the
RNAimage Kit protocol (GenHunter Corp., Nashville,
Tennessee). The reverse transcription reaction contained
0.4 μg of DnaseI-treated RNA, 0.2 μM anchor primer, 1×
first strand buffer (50 mM Tris-HCl pH 8.3, 75 mM KCl, 3
mM MgCl2), 0.5 mM dithiothreitol and 20 μM dNTP's).
Samples were heated to 42°C for 2 min and 200 U Super-
script II reverse transcriptase (Invitrogen) was added. The
samples were further incubated at 42°C for 50 min, fol-
lowed by incubation at 70°C for 15 min to inactivate the
reverse transcriptase.
Differential mRNA display reactions were performed as
described in the RNAimage Kit protocol with the excep-
tion of reaction volume that was reduced to 10 μl. PCRPage 2 of 10
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mM KCl; 1.5 mM MgCl2, 0.001% gelatin), 2 μM dNTPs, 2
μM arbitrary 5'-upstream primer, 0.2 μM anchor primer,
0.1 μl α[33P] dATP (1,000 Ci/mmol), 0.5 U Amplitaq
polymerase (Perkin-Elmer, Foster City, Califomia), and 1
μl of first- strand cDNA. The cDNA sequences were ampli-
fied by PCR in a Perkin-Elmer model 2400 thermocycler
using the following profile: 94°C for 30 sec, 40°C for 2
min, 72°C for 30 sec. Following completion of 40 cycles,
the reactions were incubated at 72°C for an additional 5
min. Bands specific for P. y. nigeriensis that were affected
by chloroquine were identified using the anchor primer
H-T11A (5'-AAGCTTTTTTTTTTTA-3') and the 5' upstream
primers H-AP18 (5'-AAGCTTAGAGGCA-3') and H-AP19
(5'-AAGCTTATCGCTC-3') obtained from GenHunter
Corp. The bands were excised from the gel and reampli-
fied by PCR using identical PCR conditions described
above with the exception that α[33P] dATP was omitted.
The reamplified cDNA fragment was purified from a 1.5%
agarose gel and subcloned into the pCR2.1 vector using
the TA Cloning Kit (Invitrogen).
Dot blot analysis
Genomic dot blots were prepared using 2 μg P. y. nigerien-
sis DNA and 5 μg of An. stephensi DNA. The DNA was
denatured by heating at 95°C for 10 min and cooled on
ice. DNA was then blotted directly onto positively charged
nylon membrane (Roche, Portugal) and cross-linked by
UV exposure. The blots were incubated overnight at 55°C
in hybridization solution (DIG Easy Hyb Granules,
Roche) containing a probe labeled with DIG-dUTP by
PCR (PCR DIG Probe Synthesis Kit, Roche). Filters were
washed twice in 2× SSC, 0.1% (w/v) sodium dodecyl sul-
fate (SDS) for 5 min at room temperature and then twice
in 0.1 × SSC, 0.1% SDS for 15 min at 65°C. Washing,
blocking and detection were performed with the DIG
Wash and Block Buffer Set (Roche), according to manu-
facturer instructions. After luminescent reaction with
CSPD, filters were exposed to Lumi-Film Chemilumines-
cent Detection Film (Roche) at room temperature.
Sequencing
Clones of interest were sequenced using the AGAC facili-
ties at the University of Minnesota or at the STABvida
cooperation (Lisbon, Portugal) using M13 universal prim-
ers. Sequences obtained were used to design gene specific
primers that were used in the expression analyses by Real-
Time PCR. Sequences were deposited at GeneBank under
the accession numbers [GenBank: EF451823, GenBank:
EF451824].
Real-time reverse transcriptase-PCR analysis
One μg of total RNA purified from infected midguts col-
lected at day 8 p.i and at day 18 p.i. and from infected sal-
ivary glands collected at day 18 p.i. was treated with
DNase I as described above. Treated RNA was added to
13.5 μl of a solution containing 50 mM Tris-HCl pH 8.3,
75 mM KCl, 3 mM MgCl2, 10 mM BSA, 0.5 mM dNTP's
(Promega, Southampton, UK), 0.5 μg oligodT15
(Promega, Southampton, UK), and 10 U MMLV-RT(Invit-
rogen). RNA was reverse transcribed 1 hr at 37 C, dena-
tured 5 min at 95°C and cooled on ice.
PCR reactions was performed using qPCR™ Core Kit for
Sybr™ Green I (Eurogentec, Seraing, Belgium) containing
1× PCR buffer, 0.2 mM dNTPs, 3.5 mM MgCl2, 1:66000
Sybr Green dilution, 0.5 U of Hot GoldStar enzyme and 1
μl of first-strand cDNA reaction in a total volume of 20 μl.
Gene-specific primers for the P. yoelli ldh (5'-CCAG-
GAAAAAGTGACAAAGAATG-3'; forward primer 0.3 mM,
5'-AAACACCACCTAATCCAACAATC-3'; reverse primer,
0.3 mM), Pyn_chl055 (5'-AGCAGAAAAAGTTGAGGCAG-
TAGA-3'; forward primer 0.2 mM, 5'-GGATGTTTCAG-
TATATTCGGTTTTT-3'; reverse primer 0.3 mM) and
Pyn_chl091 (5'-TTATGCATTTTATTACTTTTGGTGAG-3';
forward primer 0.3 mM, 5'-ATCTCTAACTTTTCATTTTC-
CTTGTA-3'; reverse primer, 0.3 mM) were used in the PCR
reaction. Amplification and detection of specific products
was performed with the GeneAmp® 5700 system (PE
Applied Biosystems, Porto, Portugal) using the following
cycle profile: one cycle at 48°C for 30 min, one cycle at
95°C for 10 min, 40 cycles at 95°C for 15 s, and 60°C for
1 min. Quantification relied on the comparison of the
critical threshold cycle (Ct) of an unknown sample
against a standard curve of known quantities. Ct is the
amplification cycle at which the fluorescence becomes
detectable and is inversely proportional to the logarithm
of the initial amount of template DNA. For each reaction
a standard curve was plotted with Ct values obtained from
amplification of known quantities of gDNA (100, 10, 1,
0.1 and 0.01 ng) isolated from P. y. nigeriensis or An.
stephensi. Concentration of DNA was determined by spec-
trophotometric analysis of optical density at 260 nm
(GeneQuant, Pharmacia) and standard DNA solutions
were prepared. The standard curves were used to trans-
form Ct values to the relative number of DNA molecules.
Triplicates of each sample and standard curve were per-
formed in all assays. The quantity of cDNA for each exper-
imental gene Pyn_chl055 and Pyn_chl091 was
normalized to the quantity of the housekeeping gene ldh
cDNA in each sample. Melting curves were used to deter-
mine the specificity of PCR products.
Parasite load
To estimate the parasite burden in midguts and salivary
glands of An. stephensi, the values obtained for the Pyldh
gene were used after normalization to the amount
obtained for the S7 gene of A. stephensi. To validate the
quantification method, known amounts of sporozoites
were used to assess the ability of the real-time PCR assayPage 3 of 10
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sites. An. stephensi infected with P. y. nigeriensis were dis-
sected at day 18 p.i., salivary glands were collected and
homogenized in a glass tissue grinder. Sporozoites were
washed and resuspended in a known volume of RPMI.
The number of sporozoites was determined using a Neu-
bauer chamber. The initial amount of 10,000 parasites
was diluted ten-fold up to one parasite. The values
obtained from the sporozoite titration were then corre-
lated with the values obtained for the standard curve used
during the experiment and with the Ct values obtained.
Erythrocytic cycle
The effect of chloroquine on the expression of the genes
isolated in the sporogonic cycle was analysed during the
erythrocytic cycle of P. y. nigeriensis. C57BL/6 mice, 6–8
weeks old, were inoculated intraperitoneally with 107 PE.
When parasitaemia reached 10–15%, the mice were
treated with 0, 0.5, 5 and 50 mg/Kg body weight. Blood
was collected at 2, 24, 48 and 72 h and was processed for
RNA extraction. Blood smears were performed for each
sample, in order to calculate parasitaemia. Real-time PCR
analyses were performed as described for sporogonic
forms.
Statistical analysis
Statistical significance was assessed by Mann-Whitney U-
test when comparing chloroquine-treated and non-
treated-controls. Comparison between different time
points was performed with the Kruskal-Wallis test, fol-
lowed by multiple-comparison test. P values less than
0.05 were considered significant. Mann-Whitney U test
and Kruskal-Wallis test were performed using SPSS v 13.0
for Windows (SPSS, Inc.).
Results
The effect of a second blood meal containing chloroquine
on the gene expression of P. y. nigeriensis during the spo-
rogonic cycle was investigated using differential display
RT-PCR (DDRT-PCR). RNA isolated from infected mid-
guts and salivary glands was reverse transcribed and
amplified by PCR using 8 mer arbitrary upstream primers.
PCR products were run on a sequencing gel (Figure 1).
The differentially-displayed bands were excised, re-ampli-
fied and cloned. The clones were used to generate probes
for dot blot analyses, in order to determine if cDNA was
of parasite or mosquito origin. This technology, allowed
the isolation of a large number of differentially displayed
genes that were mainly from mosquito origin. Two tran-
scripts that hybridized solely to P. y. nigeriensis DNA were
identified and further characterized.
The clones corresponding to differentially regulated P. y.
nigeriensis genes (thereafter named Pyn_chl091 and
Pyn_chl055) were sequenced. When the obtained
Differential display RT-PCR analysis of total RNA isolated from infecte  Anopheles stephensi midgutsFigu  1
Differential display RT-PCR analysis of total RNA iso-
lated from infected Anopheles stephensi midguts. 
Example of a sequencing gel. Mosquitoes had a second blood 
meal with or without (w/o) chloroquine at day 3 post-infec-
tion. Midguts were collected at day 8 (D8) and at day 18 
(D18) post-infection. Arrow indicates the band that origi-
nated clone Pyn_chl055. Lanes 1 and 2 represent independ-
ent experiments.Page 4 of 10
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sequences at TIGR [6] an almost complete match with ten-
tative consensus sequences was obtained (Table 1), con-
firming the origin of the gene obtained by dot blot
analyses. Sequence similarity search was performed
against TIGR, PlasmoDB and GeneDB databases, showing
strong similarities with other Plasmodium species pre-
dicted proteins, P. berghei, Plasmodium vivax, Plasmodium
chabaudi and Plasmodium knowlesi (Figure 2).
The obtained sequences were used to design specific prim-
ers that were used in Real-Time PCR analyses. Parasites
infecting mosquitoes that had a second blood meal with
chloroquine when compared with infected mosquitoes
that had a second blood meal without chloroquine
showed an increase expression of Pyn_chl091 (Figure 3A).
Expression of Pyn_chl091 was one log higher at day 18
post-infection in mosquito midgut that had a second
blood meal containing chloroquine (p = 0.039). No dif-
ferences were observed between treated and non-treated
at day 8 (1.2 fold increase). Parasites in salivary glands at
day 18 display a 2.3 fold increase of Pyn_chl091 (p =
0.063) that was not statistically significant.
Expression of Pyn_chl055 was not markedly affected by
the presence of chloroquine in the mosquito blood meal.
Only a slight increase in expression was observed at day 8
and at day 18 p.i. in both midguts and salivary glands
(Figure 3B). Differences in expression were observed com-
paring D8 with D18 midgut or salivary glands on both
treated (p = 0.037, p = 0.019) and non-treated (p = 0.001
and p = 0.003). Expression of Pyn_chl055 increased five
times between parasites at day eight in midguts and para-
sites at day 18 in salivary glands regardless of treatment.
Parasite load
In order to confirm the effect of a second blood meal con-
taining chloroquine on parasite infectivity during sporo-
gonic cycle, parasites were quantified in two different
mosquito tissues (midgut and salivary gland) using quan-
titative RT-PCR. Experiments were designed to assess the
usefulness of this technique to detect different numbers of
P. y. nigeriensis parasites in the mosquito vector. P. y.
nigeriensis sporozoites were collected from infected An.
stephensi mosquito salivary glands. The number of sporo-
zoites was counted and serial diluted. RNA was extracted
and reverse transcribed into cDNA. Real-time PCR was
performed using Pyldh primers. At the same time the
standard curve was also amplified. Correlation analyses
using three experiments showed a strong correlation
between the number of sporozoites and the Cts obtained
and between the number of sporozoites and the standard
curve used through out the experiment (Figure 4).
To obtain parasite load in the mosquito tissue data was
normalized with the expression of the mosquito constitu-
tive gene that codes for the S7 ribosomal protein. At day 8
post infection, the number of parasites in the midgut of
chloroquine-treated mosquitoes was similar to non-
treated mosquitoes, but at day 18 the parasite load
increased in the salivary glands (Figure 5). The highest dif-
ference between treated and non-treated mosquitoes was
observed in the salivary glands at day 18, where approxi-
mately a log higher parasite load was observed (p =
0.049).
Erythrocytic cycle
In order to evaluate the effect of chloroquine treatment on
Pyn_chl091 and Pyn_chl055 expression during the eryth-
rocytic cycle, experimentally infected mice were treated
with different doses of chloroquine and the expression
levels were monitored at 2, 24, 48, and 72 hours. Parasi-
taemia decreased with treatment until 48 h in a dose-
dependent manner. However, at 72 h post-infection, for
all chloroquine doses parasitaemia raised as in non-
treated mice (Figure 6). No major differences were
observed on the expression of Pyn_chl091 or Pyn_chl055
till 48 h. At 72 h after treatment, a dose dependent
decrease of Pyn_chl055 expression was observed (p =
0.038 for 50 mg/kg body weight treatment) (Figure 7).
Discussion
The effect of chloroquine on Plasmodium infectivity to the
mosquito has been addressed by several studies using dif-
Table 1: BLASTn search of Pyn_chl091 and Pyn_chl055 at TIGR Plasmodium yoelii Gene Index* [6]
Clone Identifier Species** Score Smallest Sum Probability Identities
P(N) N
Pyn_chl091 TC8060 Pyy 2919 3.0e-151 2 601/640 (93%)
BF295928 Pb 2457 2.1e-106 1 549/627 (87%)
TC3830 Pv 1013 1.2e-41 1 349/545 (64%)
BF296810 Pb 545 4.7e-20 1 113/118 (95%)
Pyn_chl055 TC7886 Pyy 489 1.2e-31 3 101/105 (96%)
* Assessed November 2006
** Pyy, Plasmodium yoelii yoelii; Pb, Plasmodium berghei; Pv, Plasmodium vivaxPage 5 of 10
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Sequence alignments of translated sequences of Pyn_chl091 and Pyn_chl055Fig re 2
Sequence alignments of translated sequences of Pyn_chl091 and Pyn_chl055. Pyn_chl091 [GenBank: EF451823] (A) 
and Pyn_chl055 [GenBank: EF451824] (B and C) with other Plasmodium predicted protein sequences. PB107300.00.0, Plasmo-
dium berghei hypothetical protein, gi68010828; PK13_6530w, Plasmodium knowlesi hypothetical protein at geneDB; v115155, 
Plasmodium vivax hypothetical protein at PlasmoDB; PY01982, mature-parasite-infected-erythrocyte-surface-antigen-putative-
prot gi83282560; PB000698.02.0, hypothetical protein, gi68075557; Plasmodium chabaudi hypothetical protein PC406006.00.0, 
gi56518416. B, ORF1 [5'3'frame 2]; C, ORF2 [3'5' frame3].
A
                           10        20        30        40        50        60        70        80        90       100 
                  ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pyn_chl091        NKILRNNTLLYIKFVCKMTANSK-IINLSIFFSINAFYMLLYIFNHTFIQVISTLCILLLLVSGLFVFLQVNTVSGYKENEKLEIVSKKALEGFITYLYE  
Pb_PB107300.00.0  -----------------..P...-...................................................D................S.......  
Pk_PK13_6530w     -----------------.NM...N.V.....A....L.I......Q..L...C........L...L.....HK..E....D.......EMI.SCVM.I..  
Pv_v115155        -----------------.NL...N.V.M...A....L.I......Q..L...C........L...L.....HK..D...SD.......EII.SC.M.I..  
                          110       120       130       140       150       160       170       180       190  
                  ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|.. 
Pyn_chl091        LITDKLTLVRKYLLWKNKMENLTVIVVIYLIGNFFSFVNFSVLFYIITWGIFLYNHISNVYIKKIYAVAHPCYVDLKEQMKYVYENIPKLKHIKKNI  
Pb_PB107300.00.0  I.N.......................I......................................................................  
Pk_PK13_6530w     ..N....IA......T.R...V.ILI.F.SV...L..I...........A.......N....T..CKLV..Y.....DHA..MFD..........T.  
Pv_v115155        ..N............N.R...V...I...SV...L..........MV..A.......N....T..CEL...Y....RD.A..MFD..........T.  
B
                          1010      1020      1030      1040      1050      1060      1070      1080      1090     1100 
                  ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pyn_chl055_ORF1   -SLEAAKKAEEKVEAAEKVEAVEK----------VEAAEKVE-------------AAEKVEAAEKVEVAEKVEVAEKVE---------------------  
Py_PY01982        HDN.QDD.DSK.S.ENDSESNSN.NGKNGKNGKNEMVLN.TKSEINEVALNKT--ETA.CDDK...K.HKEISLNKN.KNIPSLKDLKKEKDKNILIKTD  
Pb_PB000698.02.0  YDT.KVD.DSK.I.ENDPESNSN.NVKN------..CE..TKSEINEMVLNKTKLET..CDDKQ..KIHKEICLKKNAKNIPSLKDLKKEKDKNILIKTD  
                          1110      1120      1130      1140      1150      1160      1170      1180      1190     1200 
                  ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pyn_chl055_ORF1   --------------AAEKVEEKVEEKVEENKDEEN-----------------------------------------------------------------  
Py_PY01982        N---NTNERKFIEK.VK.NI..ML..E.IE....SEKTWDPTDLSLFNTSETISKIMNLKLFSSVQENINDNIEKSFALNSSEKTAVANAEKEEEKEEEK  
Pb_PB000698.02.0  NNINNINERKFIEK.VK.NI..ML..E.IE....SGKTLDPTDLSLFNRSETISKIMNLKLFSSVQENNKSEIVKNSQNN-------CNPLNQENRNDAI  
                          1210      1220      1230      1240      1250      1260      1270      1280      1290     1300 
                  ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pyn_chl055_ORF1   -------------------------------------------------KDEEN-------------------------------------KAEEN----  
Py_PY01982        KEEKDEKKDEEKDEKKDEKKDEKKDEEKEEEKEKESGEPHLDKTANTSS.NQ.QSTSKIVSKIGISKKFAFKFPLKASKHCVSKGSVEAAK....KVEAV  
Pb_PB000698.02.0  KRSFTFKSIEKMSIANSEK-------------EKETREPHIDKGANTSSN.Q.QNTSKVPSKIVISKKLTSKFSLKSNKNCIFKGNVEAVE.V.K.VEEI  
                          1310      1320      1330      1340      1350      1360      1370      1380      1390     1400 
                  ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pyn_chl055_ORF1   -------------------------KAEENKAEEKNEKDNFVTKKPNILKHPLKAKMETPSLPKNNVEKALIKKK-------------------------  
Py_PY01982        EKVEAAEKVEAVEKVEAAEKVEAAE.V....D.......D.................PG--I............NNFIKKLNNIKNVLPSKELPIKNVKI  
Pb_PB000698.02.0  EQVEK--KVEAVEKIE--------E.N.T.Y..H.-K...C....S....DH.....AC--.S.R.........NNFIKKLNTIKNILPLKELPIKNGNN  
C
                           10        20        30        40        50        60        70        80        90       100 
                  ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pyn_chl055_ORF2   ------------FFFIRAFSTLFLGRLGILAFKGCFSIFGFLVTKLSFSFFSSALFSSALFSSALFSSSLFSSSLFSSTFSSTFSSTFSAASTFSATSTF  
PC_PC406006.00.0  MFFKLFSFLMKL.....T........P-.........M....AA...G----------------------------------------------------  
                          110       120       130       140
                  ....|....|....|....|....|....|....|....|....|. 
Pyn_chl055_ORF2   SATSTFSAASTFSAASTFSAASTFSTASTFSAASTFSSAFFAASKL
PC_PC406006.00.0  ----------------------------------------------
Malaria Journal 2007, 6:84 http://www.malariajournal.com/content/6/1/84ferent species and strains of Plasmodium. Conclusions var-
ied, indicating either a significant increase of infection
intensity [2-5,7,8] or no differences between chloroquine-
treated and non-treated mosquitoes[9,10]. The present
report shows higher parasite load in salivary glands of
chloroquine-treated mosquitoes when compared to non-
chloroquine treated mosquitoes, confirming that chloro-
quine can modulate Plasmodium infection in the mos-
quito.
The anti-malarial action of chloroquine is restricted to
blood stages and several theories exist to explain chloro-
quine mechanisms of action on Plasmodium erythrocytic
stages, including i) Intercalation into GC-rich DNA, ii)
Inhibition of ornithine decarboxylase to block polyamine
metabolism, iii) Inhibition of haem-dependent protein
synthesis, iv) Increased vacuolar pH, v) Inhibition of vac-
uolar phospholipase, vi) Inhibition of haemoglobin pro-
teases, vii) Inhibition of hydrogen peroxide degradation
of haem, viii) Inhibition of glutathione degradation of
haem in the cytosol and ix) Inhibition of malarial pig-
ment formation (reviewed by Sullivan [11]). Some of
these mechanisms may be oversimplified and most likely
a combination of them is probably in action. However,
the effect of chloroquine on the sporogonic cycle is prob-
ably of different nature as the drug does not kill parasites
during this stage of development where environment and
metabolism are different. Chloroquine has applications
other than anti-malarial use, namely as an anti-inflamma-
tory drug. In this context, chloroquine activity as a lyso-
somotropic agent has been largely documented. Most of
the described effects of chloroquine can be attributed to
alterations of intravesicular pH that will interfere with sev-
eral membrane and recycling processes of the cell (e.g.
[12,13]).
Chloroquine was fed three days after an infectious blood
meal, at the time when parasites were already at the early
oocyst stage. Here, the parasite multiplies at high rates in
order to generate thousands of sporozoites. Given the
published information on chloroquine mechanisms of
action, it is expect that chloroquine might be altering the
pH of oocyst intracellular vesicles, influencing trafficking
and recycling, and, therefore, interfering with the produc-
tion of sporozoites. The genesis of the sporozoite within
the oocyst involves subdivision of cytoplasm by multiple
clefts of plasmalemma forming large vesicular structures
of ER origin that are called sporoblasts. These structures
are covered with the circumsporozoite (CS) protein
[14,15]. CS protein and GPI-anchor to this protein are
essential for the formation of sporozoites [16,17].
Anchorage of GPI is done in the ER [18], and chloroquine
through cell trafficking and recycling interference might
unbalance this complex intra-oocyst maturation of sporo-
zoites, leading to faster maturation of sporozoites and
subsequent higher parasite load at day 18 in the salivary
glands of mosquitoes that received chloroquine.
Chloroquine could also be acting directly on DNA, alter-
ing the expression of Plasmodium genes. Early work on this
drug has shown that chloroquine can act as DNA-interca-
lating agent [19] and this mechanism was used to explain
the antimalarial effect of the drug [20]. This is no longer
accepted as the mechanisms behind anti-Plasmodium
action, but can help understanding differences in gene
Expression levels of two P. y. nigeriensis transcripts isolated by DDRT-PCRFigure 3
Expression levels of two P. y. nigeriensis transcripts 
isolated by DDRT-PCR. A) expression profile of the dif-
ferential display cDNA transcripts corresponding to clone 
Pyn_chl091; B) expression profile of the differential display 
cDNA transcripts corresponding to clone Pyn_chl055. 
Quantification of cDNA was determined against a standard 
curve and normalized with the expression of Pyldh. Values 
represent the mean and standard error of 4 independent 
experiments. w - with chloroquine treatment; w/o - chloro-
quine treatment; D8 - day 8 post-infection; D18 - day 18 
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some milieu. It is also known that chloroquine enhances
transgene expression in polycation-based, nonviral gene
delivery systems and most recently data suggests that it
interacts directly with nucleic acids in cells [21] facilitating
this transgene expression. Even so, direct action on para-
site DNA is probably minor as chloroquine tends to inter-
calate in C and G reach regions [20] and Plasmodium
genome is highly reach in A and T, further the amount of
chloroquine reaching the oocysts in the mosquito is far
lower from that used to demonstrate chloroquine DNA
intercalating action. Less likely, stability of mRNA could
also have been impaired as suggested by the work of Jang
and collaborators [22] in which chloroquine reduces the
levels of IL-1 and IL-6 mRNA in mouse macrophages stim-
ulated with LPS, at least in part, by decreasing their stabil-
ity.
The two upregulated P. yoelli nigeriensis transcripts
(Pyn_chl091 and Pyn_chl055) were similar to ESTs well
represented in two P. yoelii libraries ([23] and P. yoelii EST
project at TIGR), and showed high homology with P.
berghei transcripts [24]. However, similarities with P. falci-
parum proteins were not very strong especially for
Pyn_chl091.
The Pyn_chl091 sequence, although without a strong
homology with assigned function proteins, was closely
similar to other Plasmodium. These predicted proteins
were annotated at PlasmoDB (assessed at November
2006), has having a signal peptide and transmembrane
domains, suggesting that it is a membrane protein. When
Pyn_chl091 ORF sequence was compared at Pfam data-
Validation of the parasite quantification assayFigure 4
Validation of the parasite quantification assay. (A) Correlation between the sporozoite titration and the threshold 
cycles (Ct) and (B) Correlation between sporozoite titration and the values obtained with the DNA standard curve used dur-
ing the Real Time PCR assays.
A B
Effect of chloroquine on the parasite load of Anopheles stephensi mosquitoes infect d with P. y. nigeriensisFigure 5
Effect of chloroquine on the parasite load of Anophe-
les stephensi mosquitoes infected with P. y. nigeriensis. 
D8 – day 8 post-infection; D18 – day 18 post-infection; mg – 
midgut; sg – salivary glands. Mosquitoes had a second blood 
meal three days post-infection with or without chloroquine. 
Values represent the mean and standard error of three inde-
pendent experiments. * Represents statistic significance.Page 8 of 10
(page number not for citation purposes)
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predictive value (e-value of 0.089). The function of reticu-
lon is unknown, but it has been associated with the endo-
plasmic reticulum (INTERPRO entry IPR003388).
Chloroquine is known to act at lysosome, endosome and
trans-Golgi compartments by increasing their pH and has
been used to distinguish between these compartments
and others that are independent of an acidic environment
such as endoplasmic reticulum [25]. Knowing that chlo-
roquine has a profound impact on cellular traffic the dif-
ferences in the transcription profiles of Pyn_chl091, a
putative membrane protein, are probably a result of this
effect.
The Pyn_chl055 sequence was similar to putative protein
named mature-parasite-infected erythrocyte surface anti-
gen. Its name is not in consonance with its expression at
the sporogonic cycle. Expression of Pyn_chl055 increases
towards the end of the sporogonic cycle being highest at
the salivary glands. Chloroquine had no major impact on
the transcript abundance of Pyn_chl055 during the sporo-
gonic cycle, but treatment of blood stages with chloro-
quine down-regulated the expression of this gene,
suggesting that it might be regulated by chloroquine treat-
ment during the erythrocytic cycle, further studies are
needed to confirm its involvement on chloroquine anti-
malarial effect.
Conclusion
Membrane proteins can play an important role on the reg-
ulation of drug accumulation and trafficking and chloro-
quine induction of Plasmodium transcripts for encoding
membrane proteins and transporters have been described
in other studies [26]. P. yoelii nigeriensis genes, up-regu-
lated when mosquitoes received a second blood meal on
chloroquine-treated mice, were identified and associated
with increased infectivity to the mosquito. Further, one of
these genes was also regulated by the presence of chloro-
quine during erythrocytic cycle. Both transcripts seem to
code for membrane associated proteins suggesting that
these proteins due to their location are targets of chloro-
quine action probably through membrane trafficking that
may increase their retention at the cell surface. Depending
on their function this phenomenon could have implica-
tions on drug concentration within the cell and subse-
quent effect of the drug on the infected erythrocyte. This
study shows the importance of some antimalarial drugs in
activity non related to the blood cycle though affecting
possibly and unexpectedly malaria transmission.
Expression profiles of Pyn_chl091 and Pyn_chl055 during the erythrocytic cyc  of Plasmodium yoelii nigeriensisFigu e 7
Expression profiles of Pyn_chl091 and Pyn_chl055 
during the erythrocytic cycle of Plasmodium yoelii 
nigeriensis. Quantification of cDNA was determined against 
a standard curve and normalized by the amount of Pyldh 
expression. Mice infected with P. y. nigeriensis were given 
orally 0.5, 25, 50 mg chloroquine/kg body weight. Blood was 
collected at 2, 24, 48 and 72 hours post treatment. Values 
represent the mean and standard error of three independent 
experiments. * Represents statistic significance.
Parasitaemia of C57Bl6 mice infected with Plasmodium yoelii nigeriensisFigure 6
Parasitaemia of C57Bl6 mice infected with Plasmo-
dium yoelii nigeriensis. Mice were treated with 0.5, 5 and 
50 mg chloroquine/Kg body weight. Values represent geo-
metric mean of three independent experiments at 0, 24, 48 
and 72 hours post-infection.Page 9 of 10
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